RA Capital Management Healthcare Acquisition | M&A Deal

RA Capital Management has completed the acquisition of Research Alliance III, a healthcare services other business in New York, for $75 million. The biotech SPAC is structured to merge into an operating biotechnology company spanning drug development and commercialization, diagnostics, and healthcare technology and services. RA Capital Management acquisitions in healthcare M&A focus on identifying a platform acquisition target that can scale commercialization and clinical programs. The platform acquisition is a private equity acquisition via a blank-check vehicle that sold 7.5 million shares at $10 on Nasdaq under ticker RACC, with an expanded share offering and a stated intent to pursue a China-based healthcare deals NY target.